• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Terumo Corp ADR (OP: TRUMY )

    19.92 +0.71 (+3.70%)
    Streaming Delayed Price Updated: 9:30 AM EDT, Aug 28, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 736
    Open 19.92
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 19.21
    Today's Range 19.92 - 19.92
    52wk Range 14.06 - 41.19
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
    Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth. 
    Via Benzinga
    Why Shares of Orchestra BioMed Jumped Tuesday
    The company got approval from the FDA to go ahead with a pivotal study for a hypertension therapy. 
    Via The Motley Fool
    Exposures Product Safety

    Performance

    YTD
    -38.73%
    -38.73%
    1 Month
    +12.73%
    +12.73%
    3 Month
    +16.63%
    +16.63%
    6 Month
    -49.17%
    -49.17%
    1 Year
    -32.04%
    -32.04%

    More News

    Read More
    Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
    Via TheNewswire.com
    Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
    Via News Direct
    Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
    Via Benzinga
    With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO
    Via Benzinga
    Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
    Via TheNewswire.com
    Topics Economy
    Exposures Supply Chain
    Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
    Via News Direct
    Topics Economy
    Exposures Supply Chain
    Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
    Via Benzinga
    Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029
    Via FinancialNewsMedia
    Exposures COVID-19
    Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry
    Via Benzinga
    Inspira Technologies, The Company That Aims To Change 50 Years Of Therapeutic Paradigm In Patients With Respiratory Failure
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.